Ignite Creation Date:
2025-12-24 @ 11:45 PM
Ignite Modification Date:
2025-12-25 @ 9:38 PM
Study NCT ID:
NCT04399551
Status:
COMPLETED
Last Update Posted:
2024-04-05
First Post:
2020-05-18
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study Evaluating Implementation Strategies for Cabotegravir (CAB)+ Rilpivirine (RPV) Long-acting (LA) Injectables for Human Immunodeficiency Virus (HIV)-1 Treatment in European Countries
Sponsor:
ViiV Healthcare
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-28
Start Date Type:
ACTUAL
Primary Completion Date:
2022-03-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-03-13
Completion Date Type:
ACTUAL
First Submit Date:
2020-05-18
First Submit QC Date:
None
Study First Post Date:
2020-05-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-03-06
Results First Submit QC Date:
None
Results First Post Date:
2023-05-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-04
Last Update Post Date:
2024-04-05
Last Update Post Date Type:
ACTUAL